Drug Report History #136445
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-FR | Version v6-FR | |
|---|---|---|
| Language | French | French |
| Date Updated (Changed) | Updated to: 2021-09-21 | Was: 2021-04-15 |
| Drug Identification Number | 02439379 | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL | Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 100 mL | 100 mL |
| Additional packaging sizes | ||
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage (Changed) | Updated to: Delay in shipping of the drug. | Was: Other (Please describe in comments) |
| Anticipated start date (Changed) | Updated to: 2021-09-22 | Was: 2021-03-26 |
| Actual start date (Changed) | Updated to: 2021-09-22 | Was: 2021-03-26 |
| Estimated end date (Changed) | Updated to: 2021-09-28 | Was: Unknown |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Anticipated shortage | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: 09/21/2021: Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Ropivacaine Hydrochloride Injection, USP 2 mg/mL freeflex® Bag 100 mL effective September 22, 2021 until September 28, 2021. The product is on 50% allocation effective Aug 1, 2021. | Was: The product is on 100% allocation. |
| Health Canada comments |